SCHRODER INVESTMENT MANAGEMENT GROUP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 16 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$475,650
+2.3%
500,0000.0%0.00%0.0%
Q2 2023$465,000
+0.4%
500,0000.0%0.00%0.0%
Q1 2023$463,180
+2.0%
500,0000.0%0.00%0.0%
Q4 2022$454,230
+0.5%
500,0000.0%0.00%0.0%
Q3 2022$452,000
-55.8%
500,000
-57.0%
0.00%
-50.0%
Q2 2022$1,023,000
-72.4%
1,164,000
-72.0%
0.00%
-60.0%
Q1 2022$3,706,0004,164,0000.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 2,756,000$2,621,7832.46%
Sonora Investment Management Group, LLC 18,573,000$17,727,7271.52%
PALISADE CAPITAL MANAGEMENT, LP 2,614,000$2,483,3000.07%
Kohlberg Kravis Roberts & Co. L.P. 510,000$487,7130.02%
PINNACLE ASSOCIATES LTD 280,000$267,1540.01%
MACQUARIE GROUP LTD 3,903,000$3,732,0000.01%
HighTower Advisors, LLC 2,453,000$2,355,0000.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 2,500,000$2,357,5000.00%
CITIGROUP INC 1,754,000$1,668,5800.00%
MORGAN STANLEY 7,090,000$6,717,7750.00%
View complete list of IONIS PHARMACEUTICALS INC shareholders